Tubize-Fin

Tubize-Fin

TUB · BR · Healthcare / Biotechnology

242.60EUR+0.60 (+0.25%)

Price History

Full chart

Market Stats

Previous Close242.00
Open242.00
Day Range241.60 – 244.40
52-Week Range168.10 – 249.56
Volume11.04K
Market Cap10.67B
P/E (TTM)111.53
Forward P/E30.96
EPS2.15
Dividend Yield0.45%
Beta0.32
50-Day Avg186.53
200-Day Avg206.88

About

Financière de Tubize SA holds a stake in UCB, a biopharmaceutical company in Belgium. It focuses on the discovery and development of treatments for patients suffering from diseases affecting immune or central nervous system. The company was founded in 1928 and is based in Brussels, Belgium.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Eric Nys
  • Employees0
  • HeadquartersAllée de la Recherche 60, Brussels, Belgium, 1070, Belgium
  • Websitehttps://www.financiere-tubize.be

Leadership

  • Mr. Eric NysManaging Director
  • Ms. Anne Sophie PijckeGeneral Manager

Financials

Income Statement

Currency: EUR2000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue284.00K173.00K164.00K217.00K2.00K304.95M157.12M58.58M15.88M179.51M37.27M84.73M92.78M75.80M71.59M1.00K302.00K272.23M288.25M3.00K008.15K013.26K0
Growth (%)--39.08%-5.20%+32.32%-99.08%+15247350.00%-48.48%-62.71%-72.90%+1030.70%-79.24%+127.33%+9.50%-18.30%-5.55%-100.00%+30100.00%+90043.38%+5.88%-100.00%-100.00%---100.00%--100.00%
Cost of Revenue-------------009.12M6.75M5.12M2.14M1.25M-1.50M1.83M2.03M2.24M859
Gross Profit----2.00K--------001.00K302.00K267.12M286.11M3.00K--1.50M-1.82M-2.03M-2.22M-859
Gross Margin----100.00%--------0.00%0.00%100.00%100.00%98.12%99.26%100.00%---22327.55%--16771.11%-
Operating Expense-----292.00K--------813.00K648.00K595.00K979.00K268.06M287.06M-284.88M--381.47M2.86K114.39K12.63K2.97M
Operating Income---118.18M294.00K-534.00K68.00K102.00K507.00K-230.00K-365.00K-372.00K-381.00K-813.00K-648.00K-594.00K-677.00K-940.00K-951.00K284.88M260.94M379.97M-1.82M-2.14M-2.24M-2.97M
Operating Margin---54460.83%14700.00%-0.18%0.04%0.17%3.19%-0.13%-0.98%-0.44%-0.41%-1.07%-0.91%-59400.00%-224.17%-0.35%-0.33%9496000.00%---22362.69%--16866.37%-
EBITDA---128.87M132.15M303.56M156.63M-16.90M509.00K-6.32M-15.93M-14.69M-13.36M73.65M69.53M214.11M-5.82M-151.00K-118.00K570.88M524.13M761.48M86.89M184.57K-2.24M95.12M
EBITDA Margin---59388.94%6607300.00%99.54%99.69%-28.85%3.21%-3.52%-42.73%-17.33%-14.40%97.17%97.11%21411100.00%-1927.15%-0.06%-0.04%19029266.67%--1065987.98%--16862.90%-
Net Income---118.10M123.91M293.86M477.27M39.53M-905.00K163.31M20.87M64.69M77.81M61.71M60.84M212.53M181.19M285.93M285.16M283.70M260.52M380.09M85.17M88.15M90.10M93.23M
Net Income Margin---54422.12%6195350.00%96.36%303.77%67.48%-5.70%90.97%55.99%76.35%83.87%81.40%84.99%21252600.00%59995.36%105.03%98.93%9456800.00%--1044901.09%-679673.60%-
R&D----------------23.58--592--10.45K---
R&D as % of Total Revenue----------------0.01%--19.73%--128.19%---
Interest Expense00019.00K6.05M5.70M7.20M40.77M1.57M163.76M15.76M70.58M12.98M10.21M8.56M6.28M5.41M4.59M2.37M1.20M543.00K165.00K2.06M3.29M2.50M1.89M
Interest Expense % of Total Revenue0.00%0.00%0.00%8.76%302750.00%1.87%4.58%69.60%9.91%91.23%42.27%83.30%13.99%13.47%11.96%627900.00%1789.74%1.69%0.82%39900.00%--25306.75%-18835.33%-

Balance Sheet

Currency: EUR2000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets525.30M647.27M748.11M791.03M715.25M1.02B1.60B1.67B1.59B1.72B1.78B1.87B1.79B1.80B1.84B2.26B2.22B2.31B2.48B2.75B2.83B3.27B1.84B1.92B1.93B1.93B
Total Liabilities81.87M128.84M171.45M156.12M122.70M117.52M240.31M413.79M389.92M366.64M340.97M320.31M293.53M253.23M213.55M311.84M265.26M195.65M144.04M87.46M34.26M20.94M87.19M123.65M89.28M48.58M
Total Equity443.43M518.43M576.65M250.07M592.56M901.39M1.36B1.26B1.20B1.36B1.44B1.55B1.49B1.55B1.62B1.95B1.96B2.12B2.34B2.66B2.79B3.25B1.75B1.80B1.84B1.89B
Cash130.00K308.00K191.00K588.00K4.88M7.19M9.66M8.87M8.79M2.80M757.00K779.00K193.00K476.00K354.00K565.00K662.00K1.45M1.53M462.00K983.00K15.90M1.07M574.84K1.43M368.07K
Total Debt---124.11M112.67M103.38M223.44M-359.53M342.49M314.80M286.60M255.40M222.19M184.36M285.29M241.00M192.14M142.61M86.50M33.52M20.04M47.80M79.20M41.30M-
Net Debt---123.52M107.79M96.19M213.78M-8.87M350.74M339.70M314.04M285.82M255.21M221.72M184.00M284.72M240.34M190.69M141.08M86.04M32.53M4.14M46.73M78.63M39.87M-368.07K

Cash Flow

Currency: EUR2002-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-3.05M-12.84M327.96M5.61M5.32M-12.79M-1.12M124.00K-1.40M-823.00K-613.00K63.45M67.70M72.96M75.76M-1.15M-2.09M-1.16M174.23M-2.05M-2.07M91.84M
Investing Cash Flow-48.48M50.90M-97.38M-134.56M61.80M61.23M63.75M65.12M66.41M68.34M69.06M-67.40M74.89M78.29M80.33M82.37M84.42M61.16M-5.71M11.30M87.27M-4.38M
Financing Cash Flow--47.39M-35.75M100.08M128.16M-67.19M-54.43M-64.67M-65.23M-65.59M-67.23M-68.57M68.19M-74.09M-76.59M-79.19M-82.29M-81.80M-45.08M-7.01M-9.75M-84.35M-88.52M
Capital Expenditure00000000000000000000000
Free Cash Flow-3.05M-12.84M327.96M5.61M5.32M-12.79M-1.12M124.00K-1.40M-823.00K-613.00K63.45M67.70M72.96M75.76M-1.15M-2.09M-1.16M174.23M-2.05M-2.07M91.84M
Dividends Paid-18.80M5.92M20.22M20.67M21.11M21.41M21.41M21.41M21.41M21.41M21.41M21.38M22.28M23.17M24.06M24.93M27.60M30.27M33.38M38.28M43.18M46.31M
FCF to OCF-100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%
Dividend Paid to FCF-616.36%-46.08%6.17%368.74%396.75%-167.36%-1910.08%17267.74%-1525.07%-2601.70%-3492.99%33.70%32.91%31.76%31.75%-2173.23%-1317.96%-2602.67%19.16%-1871.02%-2086.81%50.43%

Earnings

Report DateJul 30, 2014Feb 27, 2015Jul 31, 2015Feb 26, 2016Jul 28, 2016Feb 23, 2017Jul 27, 2017Feb 23, 2018Sep 3, 2018Feb 28, 2019Aug 27, 2019Feb 20, 2020Jul 27, 2020Feb 27, 2021Aug 2, 2021Feb 28, 2022Aug 1, 2022Mar 22, 2025Aug 2, 2025Mar 20, 2027
EPS Estimate0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00-0.00--
EPS Actual0.000.000.002.762.391.683.462.964.431.973.313.062.912.944.603.943.250.002.15-
Surprise--------------------
Timing----------------Pre-market-After-hoursAfter-hours

Key Statistics & Ratios

Market Cap10.67B
Enterprise Value10.07B
Trailing P/E111.53
Forward P/E30.96
PEG Ratio1.24
Price / Sales1000000.00
Price / Book5.10
EPS2.15
Book Value44.62
Revenue (TTM)13.26K
Gross Profit (TTM)-3.03M
EBITDA-3.03M
Profit Margin0.00%
Operating Margin0.00%
Return on Equity5.02%
Return on Assets-0.10%
Shares Outstanding44.51M
Shares Float20.71M
Beta0.32
Dividend Yield0.45%
Dividend Rate1.08
Payout Ratio48.85%

Dividends

20261×
0.76May 7, 2026
20251×
0.73Apr 30, 2025
20241×
0.68Apr 30, 2024
20231×
0.60May 3, 2023
20221×
0.53May 3, 2022
20211×
0.48May 4, 2021
20201×
0.43May 6, 2020
20191×
0.39May 2, 2019
20181×
0.38May 2, 2018
20171×
0.36May 3, 2017
20161×
0.36May 5, 2016
20151×
0.36May 6, 2015
20141×
0.36May 2, 2014
20131×
0.36May 2, 2013
20121×
0.36Apr 27, 2012
20111×
0.36May 2, 2011
20101×
0.36May 3, 2010
20091×
0.36May 5, 2009
20081×
0.35Apr 29, 2008
20071×
0.35Apr 30, 2007
20061×
0.34Jun 16, 2006
20051×
0.66Jun 17, 2005
20041×
0.31Jun 11, 2004
20031×
0.28Jun 13, 2003

Stock Splits

  • Jun 17, 20052:1
  • Nov 26, 1999100:1